Stem cells and regenerative medicine
The next generation of medicine and therapy.
Leading researchers
- Professor Claude Bernard
- Professor Richard Boyd
- Professor Peter Currie
- Professor Andrew Elefanty
- Professor Graham Jenkin
- Professor Graham Lieschke
- Professor Christophe Marcelle
- Professor Nadia Rosenthal
- Professor Ed Stanley
- Professor Euan Wallace
- Professor Zhi-Cheng Xiao
- Associate Professor Sharon Ricardo
- Dr Helen Abud
- Dr Tiziano Barberi
- Dr James Bourne
- Dr David Elliot
- Dr Caroline Gargett
- Dr Tony Goldschlager
- Dr Julian Heng
- Dr Jan Kaslin
- Dr Rebecca Lim
- Dr Edwina McGlinn
- Dr Suzie Miller
- Dr Sean Murphy
- Dr Nicolas Plachta
- Dr Tamara Yawno
Insight on inflammation
Scientists' discovery of an important step in the body's process for healing wounds may lead to a new way of treating inflammation.
Interested in partnering with us?
Contact our Industry and Engagement team
Stem cells hold remarkable potential for modern medicine.
Monash scientists are searching for new treatments for disease through better understanding the role stem cells and tissue repair mechanisms play in our bodies.
The unique partnership between our School of Biomedical Sciences, the Australian Regenerative Medicine Institute and the Monash Institute of Medical Research leaves us poised to deliver the next generation of discoveries in regenerative medicine and cell-based therapy.
We have been able to generate stem cells from patients with kidney disease, Friedreich's ataxia and multiple sclerosis. We lead discoveries in tissue development and repair after injury and we are finding new ways to boost the body's regenerative ability by investigating how systems are regulated at a molecular level.
We are conducting research using a range of stem cell types, including:
- pluripotent embryonic cells
- induced pluripotent cells
- adult stem cells.
Infrastructure
Our researchers and industry partners have access to powerful facilities, including:
- StemCore
- Australian Regenerative Medicine Institute
- Monash Micro Imaging
- FishCore
- FlowCore
- ARMI Gene Recombineering Facility
- MIMR Next Gen sequencing
Working with industry
Our structure, facilities and partnerships improve the quality and scope of our research, while producing opportunities for spin-off companies, medical discoveries and improved access to commercial and intellectual ownership.
New therapies are being developed for leukemia at The Alfred Hospital and for solid tumours at Monash Health Translation Precinct.
And the Monash Institute of Medical Research is at the forefront of clinical translation of cell based therapies.
Our partners include:
- Mesoblast Ltd
- Cell Care Australia
- Stem Cells Australia
- European Molecular Biology Laboratory
- Californian Institute of Regenerative Medicine - San Francisco
- Australia-China Centre for Excellence in Stem Cells - University of Peking
- Stem Cell Network Asia Pacific
Contributing capabilities
- Neuroimmunology
- Immune regeneration
- Embryonic stem cell differentiation
- Renal regeneration
- GMP based cell isolation and production
On our site
A member of
Authorised by: Director, Office of Marketing and Communications.
Maintained by: eSolutions ServiceDesk.
Last updated: 18 February 2013.
Copyright © 2013 Monash University. ABN 12 377 614 012 -
Accessibility -
Caution -
Privacy
CRICOS Provider Number: 00008C
We acknowledge and pay respects to the Elders and Traditional Owners of the land on which our six Australian campuses stand. Information for Indigenous Australians